Skip to main content
Top
Published in: Tumor Biology 11/2014

01-11-2014 | Research Article

Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer

Authors: Xiao-Jie Bian, Gui-Ming Zhang, Cheng-Yuan Gu, Ying Cai, Chao-Fu Wang, Yi-Jun Shen, Yao Zhu, Hai-Liang Zhang, Bo Dai, Ding-Wei Ye

Published in: Tumor Biology | Issue 11/2014

Login to get access

Abstract

Dicer and Argonaute2 (Ago2) are critical components responsible not only for RNA interference but also for microRNA synthesis. The present study investigated the roles of Dicer and Ago2 in prostate cancer (Pca). First, the expression levels of Dicer and Ago2 in Pca tissues were determined by immunohistochemistry (IHC) and compared with pathological features. Next, RNA interference was used to down-regulate the expression levels of Dicer and Ago2 in the Pca cell lines LNCaP, PC-3, and DU145, and effects on proliferation, apoptosis, and cell cycle were detected using the CCK-8 assay and flow cytometry, respectively. We found that Dicer and Ago2 expression levels in Pca tissues were higher than those in adjacent benign tissues and correlated with lower Gleason patterns, with the exception of Dicer expression in localized Pca. In vitro, silencing Dicer or Ago2 inhibited cell proliferation and induced apoptosis in LNCaP, PC-3, and DU145, as well as arrested the cell cycle at the G2/M phase in androgen-dependent LNCaP, or at S phase in the androgen-independent PC-3 and DU145. Altogether these findings suggest that Dicer and Ago2 play important roles in proliferation, apoptosis, and the cell cycle in Pca and might serve as both promising biomarkers for Pca progression and potential therapeutic targets.
Appendix
Available only for authorised users
Literature
1.
go back to reference Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.PubMedCrossRef Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.PubMedCrossRef
2.
go back to reference Sakurai K, Amarzguioui M, Kim D-H, Alluin J, Heale B, Song M-s, et al. A role for human dicer in pre-RISC loading of siRNAs. Nucleic acids research. 2011;39:1510–25.PubMedCentralPubMedCrossRef Sakurai K, Amarzguioui M, Kim D-H, Alluin J, Heale B, Song M-s, et al. A role for human dicer in pre-RISC loading of siRNAs. Nucleic acids research. 2011;39:1510–25.PubMedCentralPubMedCrossRef
4.
go back to reference Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Molecular Cell. 2007;26:611–23.PubMedCrossRef Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Molecular Cell. 2007;26:611–23.PubMedCrossRef
5.
go back to reference Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.PubMedCrossRef Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol. 2009;10:126–39.PubMedCrossRef
6.
go back to reference Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Archiv : an international journal of pathology. 2011;459:431–40.CrossRef Papachristou D, Korpetinou A, Giannopoulou E, Antonacopoulou A, Papadaki H, Grivas P, et al. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. Virchows Archiv : an international journal of pathology. 2011;459:431–40.CrossRef
7.
go back to reference Papachristou D, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao U. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology. 2012;60:36.CrossRef Papachristou D, Sklirou E, Corradi D, Grassani C, Kontogeorgakos V, Rao U. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues. Histopathology. 2012;60:36.CrossRef
8.
go back to reference Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali N. Dietel M, et al. Histopathology: Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer; 2012. Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali N. Dietel M, et al. Histopathology: Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer; 2012.
9.
go back to reference Khoshnaw S, Rakha E, Abdel-Fatah T, Nolan C, Hodi Z, Macmillan D, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Research and Treatment. 2012;135:403–13.PubMedCrossRef Khoshnaw S, Rakha E, Abdel-Fatah T, Nolan C, Hodi Z, Macmillan D, et al. Loss of Dicer expression is associated with breast cancer progression and recurrence. Breast Cancer Research and Treatment. 2012;135:403–13.PubMedCrossRef
10.
go back to reference Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene. 2014;33:3099–108.PubMedCrossRef Zhang B, Chen H, Zhang L, Dakhova O, Zhang Y, Lewis MT, et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene. 2014;33:3099–108.PubMedCrossRef
11.
go back to reference Zhang X, Graves P, Zeng Y. Overexpression of human argonaute2 inhibits cell and tumor growth. Biochimica et Biophysica Acta. 1830;2012:2553–61. Zhang X, Graves P, Zeng Y. Overexpression of human argonaute2 inhibits cell and tumor growth. Biochimica et Biophysica Acta. 1830;2012:2553–61.
12.
go back to reference Shi TY, Yang G, Tu XY, Yang JM, Qian J, Wu XH, et al. Rad52 variants predict platinum resistance and prognosis of cervical cancer. PLoS One. 2012;7:e50461.PubMedCentralPubMedCrossRef Shi TY, Yang G, Tu XY, Yang JM, Qian J, Wu XH, et al. Rad52 variants predict platinum resistance and prognosis of cervical cancer. PLoS One. 2012;7:e50461.PubMedCentralPubMedCrossRef
13.
go back to reference Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol R, et al. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. The American Journal of Pathology. 2006;169:1812–20.PubMedCentralPubMedCrossRef Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol R, et al. Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. The American Journal of Pathology. 2006;169:1812–20.PubMedCentralPubMedCrossRef
14.
go back to reference Yoo N, Hur S, Kim M, Lee J, Lee S. Immunohistochemical analysis of RNA-induced silencing complex-related proteins ago2 and tnrc6a in prostate and esophageal cancers. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118:271–6.PubMedCrossRef Yoo N, Hur S, Kim M, Lee J, Lee S. Immunohistochemical analysis of RNA-induced silencing complex-related proteins ago2 and tnrc6a in prostate and esophageal cancers. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica. 2010;118:271–6.PubMedCrossRef
15.
go back to reference Boyd L, Mao X, Lu Y-J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nature Reviews Urology. 2012;9:652–64.PubMedCrossRef Boyd L, Mao X, Lu Y-J. The complexity of prostate cancer: genomic alterations and heterogeneity. Nature Reviews Urology. 2012;9:652–64.PubMedCrossRef
16.
18.
go back to reference Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.PubMedCentralPubMedCrossRef Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103:2257–61.PubMedCentralPubMedCrossRef
19.
20.
go back to reference Han L, Zhang A, Zhou X, Xu P, Wang G-X, Pu P-Y, et al. Downregulation of Dicer enhances tumor cell proliferation and invasion. International Journal of Oncology. 2010;37:299–305.PubMed Han L, Zhang A, Zhou X, Xu P, Wang G-X, Pu P-Y, et al. Downregulation of Dicer enhances tumor cell proliferation and invasion. International Journal of Oncology. 2010;37:299–305.PubMed
21.
go back to reference Bai Y, Qiu G-R, Zhou F, Gong L-Y, Gao F, Sun K-L. Overexpression of Dicer1 induced by the upregulation of gata1 contributes to the proliferation and apoptosis of leukemia cells. International Journal of Oncology. 2013;42:1317–24.PubMed Bai Y, Qiu G-R, Zhou F, Gong L-Y, Gao F, Sun K-L. Overexpression of Dicer1 induced by the upregulation of gata1 contributes to the proliferation and apoptosis of leukemia cells. International Journal of Oncology. 2013;42:1317–24.PubMed
22.
go back to reference Naoghare P, Tak Y, Kim M, Han E, Song J. Knock-down of argonaute 2 (ago2) induces apoptosis in myeloid leukaemia cells and inhibits siRNA-mediated silencing of transfected oncogenes in hek-293 cells. Basic & Clinical Pharmacology & Toxicology. 2011;109:274–82.CrossRef Naoghare P, Tak Y, Kim M, Han E, Song J. Knock-down of argonaute 2 (ago2) induces apoptosis in myeloid leukaemia cells and inhibits siRNA-mediated silencing of transfected oncogenes in hek-293 cells. Basic & Clinical Pharmacology & Toxicology. 2011;109:274–82.CrossRef
23.
go back to reference Asai T, Suzuki Y, Matsushita S, Yonezawa S, Yokota J, Katanasaka Y, et al. Disappearance of the angiogenic potential of endothelial cells caused by argonaute2 knockdown. Biochemical and Biophysical Research Communications. 2008;368:243–8.PubMedCrossRef Asai T, Suzuki Y, Matsushita S, Yonezawa S, Yokota J, Katanasaka Y, et al. Disappearance of the angiogenic potential of endothelial cells caused by argonaute2 knockdown. Biochemical and Biophysical Research Communications. 2008;368:243–8.PubMedCrossRef
24.
go back to reference McLoughlin H, Fineberg S, Ghosh L, Tecedor L, Davidson B. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285–95.PubMedCentralPubMedCrossRef McLoughlin H, Fineberg S, Ghosh L, Tecedor L, Davidson B. Dicer is required for proliferation, viability, migration and differentiation in corticoneurogenesis. Neuroscience. 2012;223:285–95.PubMedCentralPubMedCrossRef
27.
go back to reference Koscianska E, Starega-Roslan J, Krzyzosiak W. The role of Dicer protein partners in the processing of microRNA precursors. PloS one 2011;6 Koscianska E, Starega-Roslan J, Krzyzosiak W. The role of Dicer protein partners in the processing of microRNA precursors. PloS one 2011;6
Metadata
Title
Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer
Authors
Xiao-Jie Bian
Gui-Ming Zhang
Cheng-Yuan Gu
Ying Cai
Chao-Fu Wang
Yi-Jun Shen
Yao Zhu
Hai-Liang Zhang
Bo Dai
Ding-Wei Ye
Publication date
01-11-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 11/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2462-3

Other articles of this Issue 11/2014

Tumor Biology 11/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine